Skip to Content
MilliporeSigma
  • Role of the autonomic nervous system and baroreflex in stress-evoked cardiovascular responses in rats.

Role of the autonomic nervous system and baroreflex in stress-evoked cardiovascular responses in rats.

Stress (Amsterdam, Netherlands) (2014-06-07)
Daniel Gustavo Dos Reis, Eduardo Albino Trindade Fortaleza, Rodrigo Fiacadori Tavares, Fernando Morgan Aguiar Corrêa
ABSTRACT

Restraint stress (RS) is an experimental model to study stress-related cardiovascular responses, characterized by sustained pressor and tachycardiac responses. We used pharmacologic and surgical procedures to investigate the role played by sympathetic nervous system (SNS) and parasympathetic nervous system (PSNS) in the mediation of stress-evoked cardiovascular responses. Ganglionic blockade with pentolinium significantly reduced RS-evoked pressor and tachycardiac responses. Intravenous treatment with homatropine methyl bromide did not affect the pressor response but increased tachycardia. Pretreatment with prazosin reduced the pressor and increased the tachycardiac response. Pretreatment with atenolol did not affect the pressor response but reduced tachycardia. The combined treatment with atenolol and prazosin reduced both pressor and tachycardiac responses. Adrenal demedullation reduced the pressor response without affecting tachycardia. Sinoaortic denervation increased pressor and tachycardiac responses. The results indicate that: (1) the RS-evoked cardiovascular response is mediated by the autonomic nervous system without an important involvement of humoral factors; (2) hypertension results primarily from sympathovascular and sympathoadrenal activation, without a significant involvement of the cardiac sympathetic component (CSNS); (3) the abrupt initial peak in the hypertensive response to restraint is sympathovascular-mediated, whereas the less intense but sustained hypertensive response observed throughout the remaining restraint session is mainly mediated by sympathoadrenal activation and epinephrine release; (4) tachycardia results from CSNS activation, and not from PSNS inhibition; (5) RS evokes simultaneous CSNS and PSNS activation, and heart rate changes are a vector of both influences; (6) the baroreflex is functional during restraint, and modulates both the vascular and cardiac responses to restraint.

MATERIALS
Product Number
Brand
Product Description

Atenolol, European Pharmacopoeia (EP) Reference Standard
Meglumine, European Pharmacopoeia (EP) Reference Standard
USP
Atenolol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Atenolol, ≥98% (TLC), powder
Supelco
Meglumine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Meglumine, 99.0-100.5% dry basis, meets USP testing specifications
Sigma-Aldrich
N-Methyl-D-glucamine, 99.0-100.5% (titration)
Sigma-Aldrich
N-Methyl-D-glucamine, ReagentPlus®, ≥99.0% (T)
Homatropine methylbromide, European Pharmacopoeia (EP) Reference Standard
USP
Homatropine methylbromide, United States Pharmacopeia (USP) Reference Standard